Section Arrow
Quote
APUS.NYSE-M
- Apimeds Pharmaceuticals US Inc.
Quotes are at least 15-min delayed:2026/06/28 01:36 EDT
Regular Hours
Last
 0.9
+0.042 (+4.90%)
Day High 
1.07 
Prev. Close
0.858 
1-M High
1.6 
Volume 
192.10K 
Bid
0.91
Ask
1.06
Day Low
0.8501 
Open
1 
1-M Low
0.7903 
Market Cap 
12.95M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.1 
20-SMA 1.23 
50-SMA 1.49 
52-W High 5.97 
52-W Low 0.7903 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-2.78/--
Enterprise Value
13.08M
Balance Sheet
Book Value Per Share
8.38
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc4.02+0.24+6.35%37.8PE
PRGOPerrigo Company PLC9.95+0.27+2.79%-- 
HIMSHims & Hers Health33.94+1.23+3.76%-- 
UPCUniverse Pharmaceuticals Inc2.96+0.12+4.23%-- 
ZTSZOETIS76.09-1.73-2.22%12.76PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.